Yüklüyor......
An open-label study of escitalopram in body dysmorphic disorder
Body dysmorphic disorder (BDD) is a relatively common and impairing disorder. Selective serotonin reuptake inhibitors (SRIs) appear selectively efficacious for BDD, but pharmacotherapy research is limited, and escitalopram has not been studied. Fifteen subjects with BDD were treated with escitalopra...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1613831/ https://ncbi.nlm.nih.gov/pubmed/16528140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.yic.0000194378.65460.ef |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|